261Y000237/28341 - Various Medicines under Framework Agreement 2023/671

This tender, identified by reference 261Y000237/28341, relates to the procurement of various medicines under the terms of Framework Agreement (A.Q.) 2023/671. A framework agreement is a pre-negotiated contract that sets out the terms and conditions under which specific goods or services can be procured over a period of time. This tender indicates that the procuring entity is utilizing an existing framework agreement to acquire a range of different medicines. This approach streamlines the procurement process, as the main terms have already been agreed upon. The reference A.Q.2023/671 suggests that this framework agreement was established in 2023 and covers a variety of pharmaceutical products. The purpose of this tender is likely to place orders or call off specific medicines from the suppliers who are parties to this framework agreement. The objective is to ensure the continued availability of necessary medications through an efficient and pre-approved procurement channel. The tender documents will specify the exact medicines required, quantities, and the procedure for ordering under the existing framework.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 90,805.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.